Lakefront Biotherapeutics NV Net Debt Growth & History (LKFT)

Lakefront Biotherapeutics NV's net debt was −€81.0M for fiscal 2025.

View full Lakefront Biotherapeutics NV company overview

Lakefront Biotherapeutics NV annual net debt history

Lakefront Biotherapeutics NV annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−€81.0M−€28.4M
20242024-12-31−€52.5M€104.7M
20232023-12-31−€157.2M€329.0M
20222022-12-31−€486.2M€1.72B
20212021-12-31−€2.21B−€100.8M
20202020-12-31−€2.11B−€269.5M
20192019-12-31−€1.84B−€545.4M
20182018-12-31−€1.29B−€139.6M
20172017-12-31−€1.15B

Lakefront Biotherapeutics NV net debt trends

Over the last five fiscal years, Lakefront Biotherapeutics NV's net debt increased from −€2.11B to −€81.0M, a change of €2.02B. The latest reported quarter, Q2 2026, shows −€129.6M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Lakefront Biotherapeutics NV source filings ↗

Community posts

It’s quiet here.

No posts about LKFT yet. Start the conversation.

Write the first post